REVELATION BIOSCIENCES INC (REVB)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$3.56-13.59%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · REVB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 5.2 | 4.1 | 3.5 | 4.1 | 5.4 | 6.9 | — |
| Operating Income | (11.3) | (9.1) | (8.0) | (8.7) | (10.9) | (12.0) | (1.6) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | — | — | 0.0 | — |
| Interest & Investment Income | — | — | — | — | — | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | 0.0 | — |
| Other Non-Operating Income / Expenses | 0.5 | 0.2 | (7.1) | 8.5 | 0.0 | (0.0) | — |
| EBT, Incl. Unusual Items | — | — | — | — | — | — | (1.6) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | — |
| Net Income | |||||||
| Net Income | (10.8) | (8.9) | (15.0) | (0.1) | (10.8) | (12.0) | (1.6) |
| Per Share | |||||||
| Basic EPS | (2.81) | (23.95) | (87.68) | (8.44) | (149.20) | (42.50) | (0.68) |
| Diluted EPS | (2.81) | (23.95) | (87.68) | (8.44) | (149.20) | (42.50) | — |
| Basic Weighted Avg Shares | 3.8 | 0.6 | 0.2 | 0.0 | 0.1 | 0.3 | 2.4 |
| Diluted Weighted Avg Shares | 3.8 | 0.6 | 0.2 | 0.0 | 0.1 | 0.3 | — |
| Supplemental | |||||||
| EBIT | (11.3) | (9.1) | (8.0) | (8.7) | (10.9) | (12.0) | (1.6) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.